Metraipolis › archive › dc_b9935a040a2f

Impact of intensive adherence counseling on viral load suppression and mortality among people living with HIV in Kampala, Uganda: A regression discontinuity… — Europe PMC PMID:37549128

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37549128
DOI
10.1371/journal.pgph.0002240
License (as archived)
CC0-1.0
Archived
2026-10-07T12:29:21.924Z
SHA-256 of the archived text
04a58638870e89e53f6b21839b09b6a778081cb937532ed19fd362fdd0ec9d30
Stable URL of this page
https://metraipolis.com/documento/dc_b9935a040a2f

How to cite

Impact of intensive adherence counseling on viral load suppression and mortality among people living with HIV in Kampala, Uganda: A regression discontinuity… — Europe PMC PMID:37549128 — Europe PMC (en), https://europepmc.org/article/MED/37549128 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_b9935a040a2f (Metraipolis archive dc_b9935a040a2f, sha256 04a58638870e89e53f6b21839b09b6a778081cb937532ed19fd362fdd0ec9d30)
BibTeX
@misc{dcb9935a040a2f,
  title = {Impact of intensive adherence counseling on viral load suppression and mortality among people living with HIV in Kampala, Uganda: A regression discontinuity… — Europe PMC PMID:37549128},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37549128},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_b9935a040a2f; sha256 04a58638870e89e53f6b21839b09b6a778081cb937532ed19fd362fdd0ec9d30},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/37549128. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Intensive adherence counseling (IAC) is recommended for people living with HIV (PLHIV) with viral load (VL) ≥1,000 copies/ml after ≥6 months of anti-retroviral therapy (ART). We evaluated the effect of IAC on VL suppression and all-cause mortality among PLHIV on first-line ART with VL ≥1,000 copies/ml after ≥6 months of ART in Kampala, Uganda using regression discontinuity design, a quasi-experimental method for effect estimation when interventions depend on a cut-off. PLHIV just above VL ≥1,000 copies/ml cut-off who received ≥3 IAC sessions formed the intervention group while those just below the cut-off who received routine psychosocial support constituted the control group. Primary outcome was repeat VL suppression defined as VL <1,000 copies/ml approximately 9-12 months following initial VL assessment. Secondary outcome was all-cause mortality. We used logistic regression for causal-effect analysis, reported as odds ratio (OR) with a 95% confidence interval (CI). We performed sensitivity analyses to assess the robustness of findings to varying bandwidths at the cut-off. We found 3,735 PLHIV were started on ART between Nov 2020 and Nov 2021 of whom 3,199 were included in the analysis (3,085 control, 114 intervention). Within an optimal bandwidth, there were 236 participants (222 control, 14 intervention) with similar demographic and clinical characteristics. Repeat VL suppression was lower in the intervention than in the control group (85.7% versus 98.6%, p = 0.021) while all-cause mortality was similar (0% versus 0.5%, p = 1.000). In multivariable analysis, the odds of repeat VL suppression were 91% lower in the intervention than control group (OR = 0.09; 95% CI, 0.01-0.66). Findings are robust to varying bandwidths around the cut-off. We concluded IAC is ineffective in suppressing VL among PLHIV on first-line ART in Kampala, Uganda. Findings suggest a need to investigate the IAC implementation fidelity for successful translation in practice and the reasons for VL persistence beyond the suppression threshold.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLOS global public health, 2023 (prima pubblicazione 2023-08-07).
Identificativi: PMID 37549128 · PMCID PMC10406184 · DOI 10.1371/journal.pgph.0002240.
Pagina: https://europepmc.org/article/MED/37549128 — https://doi.org/10.1371/journal.pgph.0002240. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T12:01:43.303Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.